Objective: We aimed to evaluate the association between thyroid hormones and indices of obesity in a sample of euthyroid postmenopausal women. Design: Cross-sectional study. Methods: Serum levels of TSH, free triiodothyronine (FT 3 ), and free thyroxine (FT 4 ) as well as BMI and waist:hip ratio (WHR) were evaluated in 194 healthy euthyroid postmenopausal women. Ultrasonography was used to assess abdominal fat layers (subcutaneous fat (SF), preperitoneal fat (PF), and SF:PF ratio). Indices of adiposity were defined as high vs low depending on the median value of the assessed parameters. Results: After multivariate adjustment for traditional risk factors, lower FT 4 levels and a higher FT 3 :FT 4 ratio predicted higher SF mass (FT 4 , Exp(b)Z0.035, PZ0.020 and FT 3 :FT 4 , Exp(b)Z2.374, PZ0.018), whereas higher FT 3 predicted higher PF mass (Exp(b)Z2.815, PZ0.032). Women with FT 3 :FT 4 above the highest quartile had a significantly higher SF mass as compared to women in the lowest quartile (1.81G0.62 cm vs 1.54G0.46 cm, PZ0.027). BMI had a positive independent association with TSH (Exp(b)Z1.829, PZ0.018). Finally, FT 3 was significantly associated with SF mass among women with higher BMI (FT 3 , bZ0.259, PZ0.040) and women with higher WHR (bZ0.309, PZ0.020) but not among women with lower BMI or WHR values. Conclusion: Thyroid hormone levels, and in particular FT 3 , were independently associated with SF and PF in euthyroid postmenopausal women, and this association was mainly evident in women with higher BMIs. On the other hand, among traditional indices of adiposity, only TSH was positively associated with BMI. Larger prospective studies are needed to evaluate the significance of the present findings.
Introduction
The decline in estrogen levels that occurs during menopause has a significant impact on a woman's health; it increases the likelihood that a woman will develop degenerative diseases or significant metabolic dysfunction (1, 2) . Postmenopausal women are characterized by significant weight gain, increased abdominal adiposity, and decreased energy expenditure (2) . Moreover, agerelated loss of muscle mass is associated with increased fat mass, which results in an up to threefold increased risk of functional disability in postmenopausal women (3, 4) .
Consequently, traditional markers of adiposity such as BMI or waist:hip ratio (WHR) may not be ideal representatives of the distribution of fat mass that is allocated to the visceral and subcutaneous depots in postmenopausal women (3, 4, 5) .
The hypothalamus-pituitary-thyroid (HPT) axis, which is closely related to metabolic regulation, is further affected by aging (6) . Aging results in significant alterations in thyroid hormone synthesis, metabolism, and action, and the biological activity of thyroidstimulating hormone (TSH) has been observed to decrease with aging (7, 8) . Possible interactions between thyroid hormones and concomitant treatment may induce significant changes in the HPT axis (7) . Moreover, fasting and acute or chronic illness are related to the development of non-thyroidal illness, and decreased serum triiodothyronine (T 3 ) levels represent a significant confounder in the assessment of thyroid function with increasing age (7) . On the other hand, menopause per se is not directly associated with thyroid function, and vice versa. However, the clinical expression of some thyroid diseases may be modified by the cessation of menses (9) .
Apart from the well-described effects of hyper-and hypothyroidism in the regulation of key metabolic functions, variation in thyroid hormone levels within the population reference range has been shown to be related to many adverse health outcomes as well as to changes in body weight (10, 11) . In a previous study, we demonstrated an association of thyroid hormones with subcutaneous fat (SF) and preperitoneal fat (PF) in a mixed population of euthyroid men, premenopausal women, and postmenopausal women (12) . However, in addition to the effects of age and menopause, the distribution of fat that is accumulated in the SF and PF depots has been shown to be largely affected by sex (13) . Therefore, in the present study, we sought to investigate whether these associations persist in a larger sample of solely postmenopausal women, which thus excludes the effect of sex and menopause.
Subjects and methods

Subjects
The population of the present cross-sectional study was retrieved from the Menopause Clinic of the Aretaieio Hospital at the University of Athens. Our clinic, which has been active since 1998, serves both symptomatic and asymptomatic middle-aged women by providing information about menopause and offering screening and risk assessment for major morbidities that occur during midlife and beyond, such as osteoporosis, cardiovascular disease, and breast cancer. A detailed electronic file is created for each consenting woman that contains demographic, lifestyle, and anthropometric parameters as well as biochemical and hormonal assessments according to individual needs. The database entries at our clinic include a total of 3500 women who have been evaluated since 1990. Since 2005, ultrasound measurements have been offered to all women who are visiting our clinic for the first time. We originally screened 702 postmenopausal women who had ultrasound measurements on their first visit to our clinic. We excluded 167 women with missing values of thyroid hormones, 145 women with cardiovascular disease, 55 women with diabetes mellitus, 12 women who were receiving amiodarone, three women who were receiving lithium, and 126 women with abnormal levels of thyroid hormones or TSH.
After applying the exclusion criteria, 194 women remained for further evaluation.
Protocol study procedures
A detailed medical history was recorded for each subject regarding demographic and lifestyle parameters, cardiovascular disease risk factors, obstetrical and gynecological history, infertility, hirsutism, and menstrual irregularity during the reproductive years. We assessed blood pressure (systolic (SBP) and diastolic (DBP)), waist and hip circumference, weight, and height in the morning in light clothing. WHR and BMI were subsequently calculated. Patients were instructed to fast and not to smoke for 12 h before fasting venous blood samples were drawn between 0830 and 0930 h. The samples were centrifuged, and the serum was stored at K80 8C until assessment. Ultrasound fat evaluations were performed immediately thereafter. Hypertension was defined as an SBP of R140 mmHg and/or a DBP of R90 mmHg after two blood pressure measurements in each of two consecutive office visits or as the intake of antihypertensive medication. Dyslipidemia was defined as total cholesterol levels of R200 mg/dl or as the intake of lipid-lowering medication. Institutional Review Board approval was obtained by the Ethics Committee of Aretaieio Hospital.
Biochemical and hormone assays
Serum glucose was measured using a glucose assay (Abbott) with a coefficient of variation (CV) of %5% and a sensitivity of 2.5 mg/dl. A cholesterol assay (Abbott) was used to measure total cholesterol, with a total CV of %3% and a sensitivity of 5.0 mg/dl. Triglycerides were assessed by a triglyceride assay (Abbott) with a total CV of %5% and a sensitivity of 5.0 mg/dl. An Ultra HDL Assay (Abbott) was used to measure HDL cholesterol, with a total CV of %4% and a sensitivity of 2.5 mg/dl. LDL cholesterol was estimated with the Friedewald equation (LDL cholesterolZtotal cholesterolK(triglycerides/5)KHDL cholesterol).
The serum levels of insulin were measured on an Architect i1000 analyzer (Abbott Ireland Diagnostics Division, Lisnamuck, Longford, Ireland). The total CV ranged from 1.9 to 5.2%, and the analytical sensitivity (AS) was 1 mU/ml. Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as follows: fasting insulin (mU/ml)!fasting glucose (mmol/l)/22.5. TSH third generation, free T 3 (FT 3 ), and free thyroxine (FT 4 ) were measured with the Abbott Architect i1000 analyzer. The total CV and AS were as follows: TSH: CV 1.7-5.3%, AS 0.0025 mIU/ml; FT 3 : CV 2.3-5.0%, AS 1.0 pg/ml; and FT 4 : CV 3.6-7.8%, AS 0.4 ng/dl. Reference ranges were: TSH: 0.40-4.5 mIU/ml; FT 4 : 0.71-1.85 ng/dl; and FT 3 , 1.7-3.7 pg/ml.
Ultrasound measurements: regional obesity indices
Abdominal SF and PF layers were estimated by B-mode US imaging (US, 7.0 MHz, linear array transducer, Acuson 128 XP, Mountain View, CA, USA). The following measurements were obtained: minimum SF, which was defined as the minimum distance from the skin to the linea alba, and maximum PF, which was defined as the maximum distance from the linea alba to the interior surface of the liver. The ratio of SF to PF layer (SF:PF) was then calculated. The CV of these measurements, which were obtained by the same investigator, was 6.8% and was quite similar to that previously reported (14) . The measurement of the maximum PF layer that highly correlated with visceral fat has been previously described (14) . Ultrasonography is considered a reliable method for assessing regional adiposity as compared to other diagnostic procedures, such as computed tomography, dual-energy X-ray absorptiometry, and magnetic resonance imaging, and at the same time it is a comparatively simple and inexpensive procedure (14, 15, 16, 17) .
Statistical analysis
Statistical analysis was performed by SPSS version 17.0 (SPSS). Data are expressed as percent values or absolute numbers (meansGS.D.). Logarithmic transformation was used to improve distribution in cases of skewed samples, namely the SF:PF ratio. Means of continuous variables were compared between groups using t-tests for independent samples. Pearson's correlation coefficient was used to investigate correlations between continuous variables. In order to further evaluate the effect of obesity indices, we divided levels of BMI, WHR, and the SF and PF layers into values that were higher than the median and values that were lower than the median (BMI: 24.6 kg/m 2 ; WHR: 0.80 m; SF: 1.63 cm; PF: 1.26 cm; and SF:PF: 1.29). In addition, the effect of thyroid hormones was assessed in a continuous manner as well as by using quartiles of hormone levels. Multiple linear and logistic regression analysis was performed to investigate the simultaneous effect of possible confounding factors on the adiposity parameters. Statistical significance was set at the 0.05 level.
Results
The descriptive characteristics for the 194 postmenopausal women in the sample are presented in Table 1 . WHR and BMI classifications were associated with the amount of SF and PF mass; lower mean SF and PF were observed in women with BMI or WHR values that were below the median as compared to women with higher BMI or WHR levels, whereas mean values of SF:PF ratio did not differ according to BMI or WHR classification. We evaluated the association between fat mass and thyroid hormones or indices of menopausal status. Figure 1 demonstrates that mean values of thyroid hormones differed significantly according to the median of fat mass. Moreover, mean values of SF increased linearly with increasing quartiles of FT 3 :FT 4 , as is shown in Fig. 2 . In addition, by comparing mean SF values according to quartiles of FT 3 :FT 4 (i.e., Q1 vs Q2, Q1 vs Q3, and Q1 vs Q4), we observed that women with FT 3 :FT 4 within Q4 had significantly higher values of SF vs women with FT 3 :FT 4 levels in Q1 (Q1: 1.54G0.46 cm vs Q4: 1.81G0.62 cm, PZ0.027). Age at menopause and years since menopause (YSM) exhibited no significant correlation with values of SF, PF, and SF:PF. In addition, no significant differences were observed regarding mean values of SF, PF, and SF:PF when comparing women with premature vs normal menopause (data not shown).
Further exploration of the association between serum levels of thyroid hormones and anthropometric parameters revealed several additional results. Levels of TSH correlated with WHR (rZ0.157, PZ0.044), as well as with BMI (rZ0.149, PZ0.039). Low WHR exhibited only a borderline association with higher levels of FT 4 as compared to women with high WHR (1.05G0.15 ng/dl vs 1.01G0.13 ng/dl, PZ0.059, t-test for independent values). In addition, lower levels of TSH were observed in women with low BMI as compared to women with high BMI (low: 1.35G0.68 mIU/ml vs high: 1.58G0.78 mIU/ml, PZ0.035, t-test for independent values).
Evaluating the possible effect of menopause on the accumulation of fat mass in a multivariate approach, we observed that BMI as well as YSM and age at menopause significantly predicted the mean values of SF independently of age, dyslipidemia, hypertension, HOMA-IR, or smoking (Table 2) . Interestingly, early menopause exhibited a borderline positive association with SF as compared to normal menopause. Menopause had no apparent effect on the extent of PF mass or the SF:PF ratio. Finally, BMI and WHR were not associated with YSM, age at menopause, or the presence of early vs normal menopause (data not shown).
In the multivariate analysis (Table 3) , higher values of SF were associated with lower levels of FT 4 as well as with higher levels of the FT 3 :FT 4 ratio, whereas higher values of PF were associated with higher levels of FT 3 . In addition, mean BMI values were predicted only by levels of TSH, whereas mean WHR values were not associated with TSH or other thyroid hormone levels. No other significant associations were observed between any of the remaining thyroid hormones and the SF or PF layer or the SF:PF ratio. Finally, when we analyzing women with low vs high BMI or WHR separately, we observed that mean SF was only associated with FT 3 in the group of women with high BMI (model R 2 Z10.4%, bZ0.259, PZ0.040) as well as in the group of women with high WHR (model R 2 Z18.8%, 
Discussion
Serum levels of thyroid hormones within the normal range are known to be related to indices of regional adiposity. Interestingly, in the present study, although traditional adiposity indices such as BMI were mainly associated with TSH, sonographically assessed SF and PF were principally associated with FT 4 , FT 3 , and the FT 3 :FT 4 ratio. More specifically, lower SF was associated with a higher FT 3 :FT 4 ratio and lower FT 4 independently of traditional cardiovascular confounding factors. In the same vein, higher PF was independently associated with higher FT 3 levels. The association of free thyroid hormones with fat layer thickness was attenuated in lean women. Finally, YSM associated positively, whereas age at menopause negatively, with the accumulation of fat mass in the SF area. Body composition is characterized by a sexual dimorphism that emerges during the early reproductive years and is attenuated to some extent with increasing age and with menopause (13, 18) . Aging and hormonal changes related to menopause have both been associated with a reallocation of adipose tissue within the abdominal region (19, 20, 21) . Interestingly, the age-related loss of muscle mass is further exacerbated in overweight and obese individuals, contributing to an unfavorable ratio of fat to muscle (3) .
In the present study, measurements of regional adiposity exhibited significant associations with thyroid hormone levels in our sample of euthyroid postmenopausal women. The positive association between FT 3 levels and SF is in agreement with our previous study (12) , which assessed younger individuals of both sexes. In agreement with the present findings, significant positive associations between serum levels of T 3 and all of the measurements of abdominal fat, including SF, were observed in a study of 177 euthyroid overweight and obese Asian subjects of both sexes (22) . That study reported a stepwise increase in measurements of SF adiposity with increasing tertiles Mean levels of thyroid hormones compared according to the median of adiposity indices using t-tests for independent values (nZ194). 
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Clinical Study I Lambrinoudaki and others Adiposity and thyroid hormones after menopause of T 3 (22) . Similarly, FT 3 levels were shown to exhibit significant positive associations with the visceral fat area in a sample of 301 euthyroid Japanese patients with type 2 diabetes (23). Furthermore, we observed that the association between thyroid hormones and fat layers was attenuated in lean women, which indicates that body weight might interact with the association between thyroid hormones and SF layer. According to recent evidence, the HPT axis interacts with adipose tissue to mediate body weight. Thyroid hormones regulate thermogenesis and metabolism by affecting transcription factors that are involved in adipogenesis, genes that regulate lipid metabolism, and genes that regulate thermogenesis (24) . In addition, experimental evidence has shown that T 3 is associated with a catabolic effect when it is administered peripherally, resulting in a decrease in body weight. On the other hand, the injection of T 3 into the hypothalamus has been shown to result in anabolic actions, including increased appetite and possibly weight gain, in mammals (24) . Finally, fasting has been linked to increased glial deiodinase 2 activity and local production of T 3 , which promotes mechanisms that stimulate orexigenic neurons in mice (24) .
Further significant associations were observed in the present study between thyroid hormone levels and clinical measures of adiposity, with levels of TSH correlating positively and independently with BMI. A positive association between serum TSH and BMI has been shown in several population-based studies (25, 26, 27) . A recent meta-analysis that evaluated the association between serum TSH within the reference range and anthropometric measures reported controversial findings, with 18 out of 29 studies describing a positive association between measures of adiposity and TSH; however, that metaanalysis included only two prospective studies (11) . In addition, serum TSH within the reference range has been associated with BMI as well as with the presence of obesity, according to a review that was based on high-quality studies (10) . Moreover, FT 4 has been shown to be negatively associated with waist circumference by a subanalysis of the Asclepios Study (28) and also with BMI (25, 28, 29) , which is partly in agreement with the present findings. On the other hand, circulating FT 3 and total T 3 were shown to exhibit a positive independent association with BMI and waist circumference in studies that assessed euthyroid mixed-sex populations (26, 30) . Finally, serum FT 3 and FT 3 :FT 4 ratio were both positively related to BMI and WHR in the 2315 healthy euthyroid mixed-sex sample in the Asclepios Study (28) . The assessment of samples that included both men and women, differences in smoking frequency (28, 29) , and differences in obesity prevalence (26, 28, 30) may explain the observed differences with our postmenopausal population.
Contrary to the present findings, some studies have failed to establish an association between thyroid hormones and clinical measures of adiposity. No significant association between TSH levels and BMI as a continuous variable was reported in a recent retrospective analysis of euthyroid women (31) or in a cross-sectional, communitybased sample that included 1853 euthyroid men and women, even after adjusting for age and sex (29) . In a study of 201 euthyroid overweight and obese women aged 18-68 years, levels of TSH and FT 3 were independently associated only with waist circumference, whereas levels of FT 4 were not associated with any of the assessed markers of obesity (32) . Finally, no associations were observed between serum TSH or levels of FT 4 and measures of BMI in a cohort of 401 euthyroid middle-aged patients (361 women, 40 men), whereas lean and obese euthyroid patients did not differ with respect to their levels of TSH or FT 4 (33) .
However, it has to be noted that altered thyroid hormone levels in obese patients might not be related to an underlying dysfunction of the HPT gland (34) . In fact, weight excess and central obesity in particular have been associated with a higher rate of conversion of T 4 to T 3 as a result of increased deiodinase activity, leading to the development of hyperthyrotroponinemia; this finding has been regarded as a consequence rather than the cause of weight excess (34) . Moreover, elevated TSH levels do not seem to be associated with the autoimmune destruction of thyroid cells, at least in some cases of obese individuals (34) .
It is interesting to note that in the present study, BMI did not present the same associations with thyroid hormones as sonographically assessed fat indices did. BMI might not be an accurate index of adiposity in postmenopausal women (35, 36) . In fact, BMI calculation does not permit the direct assessment of body composition, because sex, menopausal status, and ethnicity may further mediate the association between BMI and percentage of body fat (37, 38) . Additionally, a prediction of total body fat percentage among older adults is better estimated by the combined application of BMI and serum levels of leptin rather than by the independent use of BMI values alone (39) . Concerning postmenopausal women, muscle atrophy resulting from aging, estrogen deficiency, and inactivity may mask the presence of adiposity in women with apparently normal BMI (40) .
The present study bears certain limitations. First, the cross-sectional design did not permit the detection of causality. Furthermore, the participants were relatively healthy with a low prevalence of cardiovascular risk factors, so the present findings cannot safely be extrapolated for the general postmenopausal population. Moreover, women with early menopause were relatively underrepresented, which made it impossible to safely extrapolate the possible effect of the type of menopause on the accumulation of fat mass.
In conclusion, in the present sample of postmenopausal women, FT 3 levels and FT 3 :FT 4 ratio were positively associated with SF, whereas FT 4 levels were negatively associated with SF. FT 3 presented a positive independent association with PF. These associations were more pronounced in women with higher BMI and in women with Declaration of interest
